Ally Health

Last updated on

Visit website

NHS problem

Over 70% of decisions made by health professionals are based on laboratory results, and yet access to testing is often slow and inefficient for patients and practitioners. In primary care settings, patients are often required to book multiple appointments, with clinicians and test centres, before obtaining a test result that can then be reviewed by that clinician.

The solution

Ally Health is launching AllyDx, a full-service remote testing package which streamlines patient handling where it matters most. AllyDx is a turnkey solution integrated into existing NHS IT systems (e.g. EMIS) and GP pathways, designed to allow clinicians to order home testing on behalf of their patients.

AllyDx oversees the manufacturing and delivery of CE/UKCA marked kits directly to patients, coordinates privately employed HCP visits if an observed sample collection is required, and integrates with NHS pathology labs to deliver results back to the clinician. Their solution is designed to support self or assisted sample collection and applicable to the most widely prescribed test types. Traceability and exceptional patient experience are provided via their proprietary, state-of-the-art patient-facing application.

Impact

To date, home testing screening programmes such as the Bowel Cancer screening programme have shown great success in unlocking quality-adjusted life-year (QALY) gains and saving costs through early detection. To take early cancer detection as an example, a 2014 Cancer Research Study highlighted that annual savings of £44 million could be made by diagnosing four main types of cancer at stage one rather than stage four.

Ally Dx would look to release most of this saving by targeting simplified screening to the most at-risk patient groups for an annual spend of approximately five million pounds. This is in addition to the huge benefits to the patient from less invasive treatment methods associated with early-stage detection. Looking beyond screening programs and focusing on primary care, their end-to-end solution would drastically reduce the amount of GP hours required to prescribe routine tests to chronically ill patients and save costs by diagnosing early through proactive checks. In turn, this solution can also help GPs reach their QOF targets where repeat or scheduled testing is required.